BRIANNA CAMPBELL: Open Payments
NPI 1679962765 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 84 payments from 19 companies in 2025. Trend: 2023 $936 · 2024 $1,573 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $225 |
| AstraZeneca Pharmaceuticals LP | 10 | $171 |
| Otsuka America Pharmaceutical, Inc. | 7 | $165 |
| Novartis Pharmaceuticals Corporation | 7 | $152 |
| Amgen Inc. | 9 | $137 |
| Janssen Pharmaceuticals, Inc | 6 | $129 |
| Sumitomo Pharma America, Inc. | 6 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $97 |
| Lilly USA, LLC | 5 | $89 |
| PFIZER INC. | 4 | $80 |
Products named: REXULTI, Ozempic, LEQVIO, SPRAVATO, GEMTESA, JARDIANCE, OTEZLA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
